Table 1 Baseline characteristics.

From: Effect of aortic valve replacement on myocardial perfusion and exercise capacity in patients with severe aortic stenosis

Participants

50

Age (years)

67 ± 8

Male

43 (86)

BSA (m2)

1.98 ± 0.21

BMI (kg/m2)

28.9 ± 4.6

HR (bpm)

68 ± 12

SBP (mmHg)

131 ± 20

DBP (mmHg)

76 ± 9

Hypertension

32 (64)

Diabetes

10 (20)

Dyslipidaemia

13 (26)

Coronary artery disease

9 (18)

Current/Ex-smoker

33 (66)

Drug history

  ACEi/ARB

19 (38)

  Beta-blocker

20 (40)

  Diuretic

12 (24)

  Statin

31 (62)

Bloods

  Creatinine (umol/l)

83 (73, 97)

  NTproBNP (pmol/L)*

197 (74, 483)

NYHA functional class

  I

7 (14)

  II

34 (68)

  III

9 (18)

Echocardiographic data

  AV Vmax (m/s)

4.38 ± 0.63

  AV MPG (mmHg)

46.4 ± 14.3

  AVAi (cm2/m2)

0.45 ± 0.13

  1. Values are mean ± SD, n (%) or median (interquartile range).
  2. *n = 41.
  3. ACEi, angiotensin converting enzyme- inhibitor; ARB, angiotensin receptor blocker; AV, aortic valve; AVAi, aortic valve area indexed to BSA; BSA, body surface area; BMI, body mass index; HR, heart rate; MPG, mean pressure gradient; NTproBNP, N terminal pro-brain natriuretic peptide; NYHA, New York Heart failure Association; SBP/DBP, systolic/ diastolic blood pressure; Vmax, peak velocity.
Back to article page